Full Press Release Details
CARLSBAD, Calif. , Nov. 7, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS ) today announced that management will participate in fireside chats at the following investor conferences:
• Guggenheim's Inaugural Healthcare Conference on Wednesday, November 13, 2024
• UBS Global Healthcare Conference on Wednesday, November 13, 2024
• Stifel 2024 Healthcare Conference on Monday, November 18, 2024
• Jefferies London Healthcare Conference on Wednesday, November 20, 2024
• Citi's 2024 Global Healthcare Conference on Tuesday, December 3, 2024
• Piper Sandler 36 th Annual Healthcare Conference on Wednesday, December 4, 2024
A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events . Replays will be available on the Ionis website within 48 hours and will be archived for a limited time.
About Ionis Pharmaceuticals For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients.
To learn more about Ionis, visit Ionis.com and follow us on X (Twitter) and LinkedIn .